DHR logo

Danaher (DHR)

Profile

Full Name

Danaher Corporation

Ticker Symbol

DHR

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

December 29, 1978

Indexes

S&P 500

Website

http://www.danaher.com

Employees

61000

Key Details

Price

$199.05(+1.19%)

Market cap

$142.45B(Mega cap)

Last Dividend

$0.32

TTM Dividend yield

0.57%

Annual revenue

$23.88B(-0.06% YoY)

Annual EPS

$5.29(-17.08% YoY)

PE ratio

38.65

Next earnings date

Jul 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$199.05
DHR price is $199.05

30-Day Relative Volume

0.71
DHR 30-day relative volume is 0.71

Price Performance

Price Most recent change

+1.19%
DHR price was up +1.19% on May 2, 2025

Price YTD change

-13.29%
DHR price is down -13.29% since January 1st

Price 1-year change

-19.36%
DHR price is down -19.36% year-on-year

Price 3-year change

-10.38%
DHR price is down -10.38% over the past 3 years

Price Range

Price All-time high

$296.06
DHR price is currently -32.77% below its historical high of $296.06

Price 3-year low

$171.00
DHR price is currently +16.40% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$142.45B
DHR market capitalization is $142.45 billion

Market cap 3-year change

-11.78%
DHR market capitalization is down -11.78% over the past 3 years

Market cap All-time high

$210.39B
DHR market capitalization is currently -32.29% below its historical high of $210.39 billion

Market cap sector rank

98.86%
DHR market capitalization is higher than 98.86% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.38%
DHR shares outstanding is down -3.38% year-on-year

Shares Outstanding 3-Year Change

-1.57%
DHR shares outstanding is down -1.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.81
DHR beta is 0.81

200-day SMA

$237.53
DHR price is currently -16.20% below its 200-day simple moving average

50-day SMA

$201.35
DHR price is currently -1.14% below its 50-day simple moving average

RSI

52.68
DHR 14-day relative strength index is 52.68

Volume

0.71
DHR 30-day relative volume is 0.71

ATR

$6.78
DHR average true range is $6.78

10-day Historical Volatility

25.09%
DHR 10-day historical volatility is 25.09%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.32
DHR last dividend was $0.32 per share, with an ex-dividend date of March 28, 2025

Next Dividend

-
DHR next dividend has not yet been announced

Dividend per share

Dividend per share

$1.08
DHR annual dividend per share is $1.08

Dividend per share Sector Rank

45.98%
DHR annual dividend per share is higher than 45.98% of companies in Healthcare sector

Dividend per share 1-Year Change

+2.86%
DHR annual dividend per share is up +2.86% year-on-year

Dividend per share 3-Year Change

+28.57%
DHR annual dividend per share is up +28.57% over the past 3 years

Dividend yield

Dividend yield

0.54%
DHR annual dividend yield is 0.54%

Dividend yield Sector Rank

16.28%
DHR annual dividend yield is higher than 16.28% of companies in Healthcare sector

Other

Payout ratio

19.70%
DHR annual payout ratio is 19.70%

Dividends paid

$768.00M
DHR annual dividends paid is $768.00 million

Free cash flow

$5.30B
DHR annual free cash flow is $5.30 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$23.88B
DHR annual revenue is $23.88 billion

Revenue Analysts estimate

$24.46B
DHR annual revenue is currently -2.37% lower than the consensus analysts' forecast

Revenue 1-year change

-0.06%
DHR annual revenue is down -0.06% year-on-year

Revenue Sector rank

96.74%
DHR annual revenue is higher than 96.74% of companies in Healthcare sector

EPS

EPS

$5.29
DHR annual earnings per share is $5.29

EPS Analysts estimate

$7.70
DHR annual earnings per share is currently -31.27% lower than the consensus analysts' forecast

EPS 1-year change

-17.08%
DHR annual earnings per share is down -17.08% year-on-year

EPS Sector rank

95.95%
DHR annual earnings per share is higher than 95.95% of companies in Healthcare sector

Profit

Gross profit

$14.21B
DHR annual gross profit is $14.21 billion

Gross margin

59.50%
DHR annual gross profit margin is 59.50%

Operating profit

$4.86B
DHR annual operating income is $4.86 billion

Operating margin

20.37%
DHR annual operating profit margin is 20.37%

Net income

$3.90B
DHR annual net profit is $3.90 billion

Net margin

16.33%
DHR annual net profit margin is 16.33%

Expenses

Total expenses

$19.01B
DHR annual total expenses is $19.01 billion

Operating expenses

$9.34B
DHR annual total operating expenses is $9.34 billion

Cost of goods sold

$9.67B
DHR annual cost of goods sold is $9.67 billion

Selling, general & administrative expenses

$7.76B
DHR annual SGA is $7.76 billion

Depreciation and amortization

$2.35B
DHR annual depreciation & amortization is $2.35 billion

Interest expense

$278.00M
DHR annual interest expense is $278.00 million

Income tax

$747.00M
DHR annual income tax is $747.00 million

EBIT & EBITDA

EBIT

$4.92B
DHR annual earnings before interest & taxes is $4.92 billion

EBITDA

$7.28B
DHR annual EBITDA is $7.28 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$77.54B
DHR annual total assets is $77.54 billion

Non current assets

$68.05B
DHR annual long term assets is $68.05 billion

Current assets

$9.50B
DHR annual total current assets is $9.50 billion

Cash and cash equivalents

$2.08B
DHR annual cash & cash equivalents is $2.08 billion

Accounts receivable

$3.54B
DHR annual accounts receivable is $3.54 billion

Inventory

$2.33B
DHR annual inventory is $2.33 billion

Liabilities

Total liabilities

$27.99B
DHR annual total liabilities is $27.99 billion

Long term liabilities

$21.19B
DHR annual total long term liabilities is $21.19 billion

Current liabilities

$6.80B
DHR annual total current liabilities is $6.80 billion

Accounts payable

$1.75B
DHR annual accounts payable is $1.75 billion

Debt

Total debt

$16.00B
DHR annual total debt is $16.00 billion

Total debt 1-year change

-18.07%
DHR annual total debt is down -18.07% year-on-year

Long term debt

$15.50B
DHR annual long term debt is $15.50 billion

Short term debt

$505.00M
DHR annual short term debt is $505.00 million

Equity & Capital

Shareholders equity

$49.54B
DHR annual stockholders equity is $49.54 billion

Book value

$49.54B
DHR annual book value is $49.54 billion

Retained earnings

$44.19B
DHR annual retained earnings is $44.19 billion

Working capital

$2.70B
DHR annual working capital is $2.70 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$6.69B
DHR annual cash flow from operations is $6.69 billion

Cash from operations 1-year change

-6.64%
DHR annual cash flow from operations is down -6.64% year-on-year

Cash from investing

-$1.98B
DHR annual cash flow from investing activities is -$1.98 billion

Cash from investing 1-year change

+72.02%
DHR annual cash flow from investing activities is up +72.02% year-on-year

Cash from financing

-$8.38B
DHR annual cash flow from financing activities is -$8.38 billion

Cash from financing 1-year change

-2971.43%
DHR annual cash flow from financing activities is down -2971.43% year-on-year

CAPEX

CAPEX

$1.39B
DHR annual capital expenditures is $1.39 billion

CAPEX 1-year change

+0.65%
DHR annual capital expenditures is up +0.65% year-on-year

Free Cash Flow

Free cash flow

$5.30B
DHR annual free cash flow is $5.30 billion

Free cash flow 1-year change

-8.39%
DHR annual free cash flow is down -8.39% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.50%
DHR annual gross profit margin is 59.50%

Operating margin

20.37%
DHR annual operating profit margin is 20.37%

Net margin

16.33%
DHR annual net profit margin is 16.33%

ROA & ROE

ROA

4.81%
DHR annual return on assets is 4.81%

ROE

7.57%
DHR annual return on equity is 7.57%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

38.65
DHR price to earnings ratio is 38.65

PE ratio Sector rank

69.76%
DHR price to earnings ratio is higher than 69.76% of companies in Healthcare sector

PB Ratio

PB ratio

2.80
DHR price to book ratio is 2.80

PB ratio Sector rank

68.6%
DHR price to book ratio is higher than 68.6% of companies in Healthcare sector

PS Ratio

PS ratio

5.98
DHR price to sales ratio is 5.98

PS ratio Sector rank

67.88%
DHR price to sales ratio is higher than 67.88% of companies in Healthcare sector

Enterprise value

Enterprise value

$156.94B
DHR enterprise value is $156.94 billion

Enterprise value Sector rank

99.26%
DHR enterprise value is higher than 99.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

21.96
DHR EV/EBITDA is 21.96

EV/EBITDA Sector rank

93.02%
DHR EV/EBITDA is higher than 93.02% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.40
DHR annual current ratio is 1.40

Quick ratio

1.05
DHR annual quick ratio is 1.05

Leverage

Debt to equity

0.32
DHR annual debt to equity ratio is 0.32

Interest coverage ratio

17.71
DHR annual interest coverage ratio is 17.71

Risk & Stability

Piotroski F-Score

8
DHR piotroski f-score is 8

Altman Z-Score

4.41
DHR altman z-score is 4.41

Analyst ratings

Recent major analysts updates

Apr 23, 25 UBS
Buy
Apr 23, 25 RBC Capital
Outperform
Apr 23, 25 Guggenheim
Buy
Apr 23, 25 Goldman Sachs
Buy
Apr 23, 25 Baird
Outperform
Apr 22, 25 Jefferies
Buy
Apr 22, 25 JP Morgan
Overweight
Apr 22, 25 Barclays
Overweight
Apr 10, 25 Barclays
Overweight
Mar 14, 25 Stifel
Buy

Institutional Ownership

Similar stocks

SYK logo
Stryker (SYK)
PFE logo
Pfizer (PFE)
SNY logo
Sanofi (SNY)
AMGN logo
Amgen (AMGN)
BSX logo
Boston Scientific (BSX)
GILD logo
Gilead Sciences (GILD)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
TMO logo
Thermo Fisher Scientific (TMO)
MDT logo
Medtronic (MDT)
  • What is the ticker symbol for Danaher?
  • Does Danaher pay dividends?
  • What sector is Danaher in?
  • What industry is Danaher in?
  • What country is Danaher based in?
  • When did Danaher go public?
  • Is Danaher in the S&P 500?
  • Is Danaher in the NASDAQ 100?
  • Is Danaher in the Dow Jones?
  • When was Danaher's last earnings report?
  • When does Danaher report earnings?
  • Should I buy Danaher stock now?

What is the ticker symbol for Danaher?

The ticker symbol for Danaher is NYSE:DHR

Does Danaher pay dividends?

Yes, Danaher pays dividends. The last payment was $0.32, with an ex-dividend date on March 28, 2025

What sector is Danaher in?

Danaher is in the Healthcare sector

What industry is Danaher in?

Danaher is in the Diagnostics & Research industry

What country is Danaher based in?

Danaher is headquartered in United States

When did Danaher go public?

Danaher's initial public offering (IPO) was on December 29, 1978

Is Danaher in the S&P 500?

Yes, Danaher is included in the S&P 500 index

Is Danaher in the NASDAQ 100?

No, Danaher is not included in the NASDAQ 100 index

Is Danaher in the Dow Jones?

No, Danaher is not included in the Dow Jones index

When was Danaher's last earnings report?

Danaher's most recent earnings report was on Apr 22, 2025

When does Danaher report earnings?

The next expected earnings date for Danaher is Jul 23, 2025

Should I buy Danaher stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page